Neuralink Plans High-Volume Brain Implant Production by 2026, Musk Says

Neuralink will begin “high-volume production” of its brain–computer interface implants and shift to a fully automated surgical procedure in 2026, according to a statement by Elon Musk.

Musk shared the update on the social media platform X on Wednesday. Neuralink did not immediately respond to a request for comment from Reuters.

The Neuralink implant is designed to help people with neurological conditions such as spinal cord injuries by enabling direct communication between the brain and computers. The company’s first patient has demonstrated the ability to play video games, browse the internet, post on social media and control a laptop cursor using only their thoughts.

Neuralink began human trials of its brain implant technology in 2024, after resolving safety concerns raised by the U.S. Food and Drug Administration. The regulator had initially rejected the company’s application in 2022, citing risks related to the device and surgical process.

In September, Neuralink said that 12 people worldwide with severe paralysis had received its implants and were using them to control both digital and physical tools through neural signals. The company has positioned the technology as a potential breakthrough for restoring independence to patients with limited mobility.

The startup has also attracted strong investor interest. In June, Neuralink raised $650 million in a funding round, providing capital to scale manufacturing, expand clinical trials and advance automation plans ahead of its targeted 2026 production push.